Zurn Elkay (ZWS) Form 4: Director sale of 2,156 shares at $47.54
Rhea-AI Filing Summary
Timothy J. Jahnke, a director of Zurn Elkay Water Solutions Corp (ZWS), sold 2,156 shares of the issuer's common stock on 09/16/2025 under a Rule 10b5-1 plan at a weighted average price of $47.54 per share. Following the reported transaction, Mr. Jahnke directly beneficially owned 308,964 shares and indirectly beneficially owned 180,000 shares held by an irrevocable trust. The Form 4 was signed under power of attorney on 09/18/2025 and notes the sale was executed in multiple trades at prices ranging from $47.50 to $47.62.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating it was preplanned and reduces concerns about trading on nonpublic information
- Clear disclosure of weighted average sale price and trade range, improving transparency
- Reporting shows substantial remaining ownership with 308,964 shares direct and 180,000 shares indirect
Negative
- Director disposed of 2,156 shares, which is a reduction in direct beneficial ownership
- Form 4 filed under Power of Attorney rather than by the reporting person directly
Insights
TL;DR: Routine, preplanned director sale under a 10b5-1 plan; does not by itself indicate governance issues.
The filing documents a small, prearranged disposition by a company director executed under a Rule 10b5-1 plan, which typically provides an objective defense against claims of trading on nonpublic information. The director remains a material shareholder with substantial direct and indirect holdings, which supports alignment with shareholders. The POA signature and explicit price range disclosure add transparency. No departures, new agreements, or unusual derivative activity are reported.
TL;DR: A routine insider sale of 2,156 shares at ~$47.54; effect on float and valuation is immaterial based on disclosed holdings.
The reported sale represents a modest reduction versus the director's total direct holding of 308,964 shares. The weighted average price and stated trade range provide clarity on execution. There is no accompanying exercise of options or derivative transactions disclosed, and no change to the reported indirect interest of 180,000 shares held in an irrevocable trust. This transaction appears administrative rather than indicative of company performance shifts.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,156 | $47.54 | $102K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transactions were executed pursuant to a Rule 10b5-1 plan. This transaction was executed in multiple trades at prices ranging from $47.50 to $47.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
